<http://schema.org/description>
"Industrial biotech and renewable oils company Solazyme hit investors with some surprising news when it reported third-quarter earnings. Management revised its 2013 guidance for total revenue"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/12/11/should-investors-expect-more-delays-at-solazyme-in/20786457/>